Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.
about
Striatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Functional development of mechanosensitive hair cells in stem cell-derived organoids parallels native vestibular hair cells.Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's DiseaseThe germline/soma dichotomy: implications for aging and degenerative diseaseChemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's DiseaseEfficient generation of hPSC-derived midbrain dopaminergic neurons in a fully defined, scalable, 3D biomaterial platform.Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.Moving stem cells to the clinic: potential and limitations for brain repairPluripotent stem cells: the last 10 years.Sorting the wheat from the chaff in dopamine neuron-based cell therapies.Optimization of the magnetic labeling of human neural stem cells and MRI visualization in the hemiparkinsonian rat brainAdvances in reprogramming-based study of neurologic disordersSuccessful function of autologous iPSC-derived dopamine neurons following transplantation in a non-human primate model of Parkinson's disease.Cell-based therapies for Parkinson disease—past insights and future potential.Monosynaptic Tracing using Modified Rabies Virus Reveals Early and Extensive Circuit Integration of Human Embryonic Stem Cell-Derived Neurons.Are Stem Cell-Based Therapies for Parkinson's Disease Ready for the Clinic in 2016?Development of stem cell-based therapy for Parkinson's disease.Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor.Excessive Wnt/beta-catenin signaling promotes midbrain floor plate neurogenesis, but results in vacillating dopamine progenitors.Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's DiseaseCyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's diseaseDopamine Receptor Antagonists Enhance Proliferation and Neurogenesis of Midbrain Lmx1a-expressing ProgenitorsDREADD Modulation of Transplanted DA Neurons Reveals a Novel Parkinsonian Dyskinesia Mechanism Mediated by the Serotonin 5-HT6 ReceptorSemaphorin 3C Released from a Biocompatible Hydrogel Guides and Promotes Axonal Growth of Rodent and Human Dopaminergic NeuronshESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.The transcriptomes of novel marmoset monkey embryonic stem cell lines reflect distinct genomic features.Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1.Scale Invariant Disordered Nanotopography Promotes Hippocampal Neuron Development and Maturation with Involvement of Mechanotransductive Pathways.The effect of magnetic nanoparticles on neuronal differentiation of induced pluripotent stem cell-derived neural precursors.Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells.An Integrated Miniature Bioprocessing for Personalized Human Induced Pluripotent Stem Cell Expansion and Differentiation into Neural Stem CellsInduced dopaminergic neurons: A new promise for Parkinson's disease.Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.In Vivo Assessment of Stem Cells for Treating Neurodegenerative Disease: Current Approaches and Future ProspectsNeural Stem Cells Derived From Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinsons Disease.Clinical translation of stem cell transplantation in Parkinson's disease.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Current status of pluripotent stem cells: moving the first therapies to the clinic.Treatment of Parkinson's disease using cell transplantation.
P2860
Q26768220-D2237BF6-ED21-4CC8-A165-ECC345E7004EQ27317317-6C6E3428-CAFC-40C2-A1FB-028F87527B45Q27329815-3AEF4FC8-C787-40B1-B899-D9BD05A4CFDEQ28067557-4B0D6B16-FDB2-4D81-8744-FED209BBDEB0Q28829174-24345647-91EE-4AF9-B47C-B34E35B1D49FQ30835073-22AF898A-2442-4E59-B89B-8D21F84343AAQ33722351-0A67DF0F-DE10-407F-8C8C-46DE348200BDQ34470920-CE627B86-B984-4829-BAD9-A8F01D081D8CQ34546417-D9E6C6C1-0DD2-45D0-9610-A723F32D5E56Q35485792-45831C3A-CDC8-4E74-ACA8-2939AD5717BAQ35559206-024AC3CE-09B2-4DB5-AF7B-A67D8871FD98Q35635245-7B53AC2E-5186-4BE5-AEB0-D40BDFF6E07BQ35711351-1502C2CC-D338-4708-8675-72A89755B9C6Q35736662-2D746A61-02CE-4BFF-A2B2-93AF65E9A990Q35754374-2741C21B-8F35-4331-956B-7B262B1AB2BCQ35966394-F5317709-1049-4ABC-825C-291B52CAFCD6Q36025246-91CA86BA-7F22-4B29-BE28-FB8AFEDEF66BQ36091067-0BC544FE-9C56-424C-AB7C-3CECB78A23ADQ36248773-E7132533-3D53-4647-BBD6-ADD7BA69EDE5Q36250893-A78A33A1-A91E-46F1-85C6-798B7CEFBE35Q36370618-AC53C8B3-39E3-4B35-A5C0-04F72386FDBAQ36953951-C5B11C9B-D319-4AF2-B7A3-6BD5C4AAA769Q36968969-81B3F5DD-6B2C-4F65-8394-C2B7155FA363Q37019996-FE7EBF1F-DCEB-4DFB-B537-1BE40192AC4BQ37037253-4A4490B0-1F28-4591-A5D0-0C67D404A56CQ37072817-A6337255-E31B-477B-A2DC-0098CD0D8ABBQ37183600-07EE13D0-343A-4843-A8A2-1AF6CB35C170Q37345425-5C0B9733-8C82-4933-A7E8-83ECABB92974Q37421179-E2BEC139-1313-47A5-BA13-C7A6F50CC080Q37446916-3D7D01DB-3ABE-4449-B631-13673138B02CQ37516524-C42A32F5-F658-4794-9E82-3A4FB29C8AD3Q37563507-20C0E2FD-055E-4888-A9E7-F2AB503E56A5Q37600465-E6D7D9A4-B563-4230-9D13-2C7F027B134EQ37643268-690A9E9A-04A8-4580-92B1-40C8A0EC819BQ37689887-BE018BF7-1F90-4C36-8187-C5EC6A1D7D3FQ38383700-E2118472-43E4-4232-A4A5-0FB2A9B1B4D8Q38579206-CB4370B1-2A02-4EED-B310-0B4FEEDC2CFDQ38587566-B025E2D0-549D-4B36-926E-2D1AE467D9F1Q38590664-7BF89D23-692F-45C7-B3CD-7121B348CCE0Q38594913-26FC8F72-931C-4970-995E-3606A22CBEED
P2860
Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@ast
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@en
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@nl
type
label
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@ast
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@en
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@nl
altLabel
Human ESC-Derived Dopamine Neu ...... t Model of Parkinson’s Disease
@en
prefLabel
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@ast
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@en
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@nl
P2093
P2860
P50
P1433
P1476
Human ESC-derived dopamine neu ...... model of Parkinson's disease.
@en
P2093
Bengt Mattsson
Elsa Diguet
Philippe Hantraye
Yann Bramoulle
P2860
P304
P356
10.1016/J.STEM.2014.09.017
P407
P50
P577
2014-11-06T00:00:00Z